Ryan M. Young

Ryan M. Young

Auto-generated profile, based on publicly available information

Ryan M. Young

National Cancer Institute

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 June 2024 in Cancer Cell
Verified
Journal Article
Closed access
ABArnold Bolomsky
Arnold Bolomsky
MCMichele Ceribelli
Michele Ceribelli
SSSebastian Scheich
Sebastian Scheich
KRKristina Rinaldi
Kristina Rinaldi
DHDa Wei Huang
Da Wei Huang
RYRyan M. Young
Ryan M. Young

7 January 2026 in OncoDaily Medical Journal
Verified
Journal Article
Open access
PDF file
EHElizabeth Hill
Elizabeth Hill
RPRoshani Patel
Roshani Patel
ABArnold Bolomsky
Arnold Bolomsky
RYRyan Young
Ryan Young
Precision medicine, as defined by individualized therapeutic targeting of oncogenic mutations, has had limited success in treating Multiple Myeloma (MM). FISH cytogenetics and next generation sequencing (NGS) have led to attempts of subtype classification, however this minimally affects treatment decisions to date. Additionally, identifying accurate and clinically available biomarkers to signal drug sensitivities has proven difficult for MM. This review discusses the previous attempts at precision medicine in MM with an in-depth focus on BCL2 inhibition. Next, select ongoing studies are reviewed including discussing relevant biomarkers being utilized in current clinical trials. Finally, we discuss potential future directions for a promising treatment approach.